Skip to main content
. 2016 Apr 27;7(23):35084–35091. doi: 10.18632/oncotarget.9041

Figure 2. Log-rank tests of cause specific comparing those who had ≥9, 3-8, and <3 negative lymph nodes for.

Figure 2

a. all stage: χ2 = 490.428, P < 0.001; b. N1 stage: χ2 = 121.351, P < 0.001; c. N2 stage: χ2 = 118.978, P < 0.001; d. N3 stage: χ2 = 163.051, P < 0.001.